ホーム › 直腸がん › ニューヨーク › New York City
New York City、NYにおける直腸がんの臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、直腸がんに関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
被験者募集中第1/2相
- NYU Langone Health Perlmutter Cancer Center, New York
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
被験者募集中
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
被験者募集中第2相
- Weill Cornell Medical College, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center, New York
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
被験者募集中
- Weill Cornell Medical College, New York
- New York Presbyterian Hospital - Queens, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- NYU Langone Medical Center, New York
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
被験者募集中
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
被験者募集中第1相
- Columbia University Irving Medical Center, New York
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
被験者募集中第2相
- Columbia University Irving Medical Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- NYU Langone Health, New York
他の都市における直腸がんの試験
- Boston, MA12件の研究
- Houston, TX11件の研究
- St. Louis, MO11件の研究
- Columbus, OH10件の研究
- Los Angeles, CA10件の研究
- Tampa, FL9件の研究
- Nashville, TN9件の研究
- Seattle, WA9件の研究
- Baldwin Park, CA8件の研究
- Salt Lake City, UT8件の研究
- Aurora, CO8件の研究
- Philadelphia, PA8件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。